Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin/Adapalene/BPO Gel vs CABTREO in Acne Vulgaris
NCT06673641Phase 1Completed
- Start
- May 2024
- Primary completion
- Sep 2024
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of clindamycin, adapalene and benzoyl peroxide + sulfur in acne vulgaris (3 arms). Primary endpoint: Demonstrate the Therapeutic Equivalence & Safety of the Investigational Product at 12 weeks. Started May 2024; status: completed.
02
Drugs
clindamycinadapalenebenzoyl peroxide + sulfur
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT06673641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06673641.